A promising target for new RNA therapeutics now accessible
RNA has long been considered only as a passive messenger in the cell, produced by DNA transcription to transfer genetic...
Chinese Medical Journal Review highlights novel pathogenic mechanisms and therapeutic potentials in cancer treatment targeting internal N6-methyladenosine and N7-methylguanine
The hematopoietic system is a complex tissue characterized by multiple layers of stem cells, progenitor cells, and mature blood cells....
AACR: Trio of studies highlights promising early results with new cancer therapies and targets
ABSTRACTS CT037, CT038, CT042Credit: The University of Texas MD Anderson Cancer Center ABSTRACTS CT037, CT038, CT042 SAN DIEGO – Three...
Periostin shows promise to help fight a common form of esophageal cancer
Philadelphia, April 9, 2024 – Esophageal squamous cell carcinoma (ESCC) accounts for around 90% of esophageal cancers, especially in East...
AACR: How cellular plasticity drives cancer metastasis
About 90% of deaths from cancer are a result of metastasis — that is, from cancer’s ability to spread from...
Study reveals mechanism linking heart disease to cancer development
Credit: Tel Aviv University Previous studies have shown that heart disease and cancer may be connected through shared risk...
Unlocking the body’s hidden weapon against cancer: the role of broken chromosomes
Scientists have unraveled the mechanisms of the Cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon genes (cGAS-STING) signaling pathway activated by...
The surprising connection between male infertility and family cancer risk
In a recent study, researchers at Huntsman Cancer Institute at the University of Utah (the U) found a surprising trend in families with male infertility: an...
Targeting vulnerability in B-cell development leads to novel drug combination for leukemia
Despite having an overall survival rate of 94%, B-cell acute lymphoblastic leukemia (B-ALL), the most common childhood cancer, can prove...
AACR: PARP1-selective inhibitor demonstrates early efficacy in breast cancers with DNA repair defects
ABSTRACT CT014Credit: The University of Texas MD Anderson Cancer Center ABSTRACT CT014 SAN DIEGO – The first-in-class PARP1-selective inhibitor saruparib...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!